TrueContour® Insole
DeviceNovel designed insole
NCT Number: NCT00803608
To assess the efficacy of TrueContour® Insoles versus the current standard of care insoles in recurrence of plantar MTH ulcers in men and women, 18 years of age or older at the time of consent with clinical diagnosis of Diabetes Mellitus type 1 or type 2 who have had at least one recently healed plantar MTH foot ulcer (>1 week but <12 weeks since heeling) and have Loss of Protective Sensation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2
Carl T Hayden VA Medical Center, Phoenix, Arizona, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Novel designed insole
Current Medicare approved A5513 insole
Time frame: every 3 months
DIApedia, LLC
Industry
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Acronym: CareFULPrevent
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04054076
Cardiovascular Diseases, Diabetes
Gothenburg, Region Västragötaland, Sweden
View Trial DetailsNCT05189470
Cardiovascular Diseases, Diabetes
Herlev, Denmark
View Trial DetailsNCT02581098
Cardiovascular Diseases, Diabetes Complications
Indianapolis, Indiana, United States
View Trial DetailsNCT02742597
Alzheimer Disease, Alzheimer's Disease
London, Ontario, Canada
View Trial Details